Söndag 11 Oktober | 13:30:07 Europe / Stockholm
Svenska | English
Kursutveckling under dagen för detta pressmeddelande (EUR).
Likviditet under dagen för detta pressmeddelande
Est. tid*
2026-10-23 09:30 Kvartalsrapport 2026-Q3
2026-08-21 - Kvartalsrapport 2026-Q2
2026-05-05 - X-dag ordinarie utdelning MODU 0.00 EUR
2026-05-04 - Årsstämma
2026-04-24 - Kvartalsrapport 2026-Q1
2026-02-20 - Bokslutskommuniké 2025
2025-10-24 - Kvartalsrapport 2025-Q3
2025-08-22 - Kvartalsrapport 2025-Q2
2025-05-05 - X-dag ordinarie utdelning MODU 0.00 EUR
2025-05-02 - Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-02-21 - Bokslutskommuniké 2024
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-05-06 - X-dag ordinarie utdelning MODU 0.00 EUR
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-10-20 - 15-10 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2023-05-02 - Årsstämma
2023-04-28 - 15-10 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2022-05-02 - Årsstämma
LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består huvudsakligen av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Modulight to publish 1H22 Half-Year Financial Report on 19 August, 2022

2022-08-12 13:00:00

Modulight Corporation, Press Release, 12 August, 2022, at 2.00 P.M. Finnish Time
 
Modulight Corporation will publish its 1H22 half-year financial report on 19 August, 2022,  approximately at 08.00 A.M. EET. 
 
Seppo Orsila, the CEO of Modulight, will present the results in a webcast starting at 10.30 AM EET. The webcast will be held in English, and can be accessed at https://modulight.videosync.fi/2022-1h22-results. Questions are requested in written format in the webcast portal. CFO Anca Guina will also join the Q&A. The material will be available on the company's website https://www.modulight.com/reports-presentations/ before the event begins.

For further information, please contact:

CEO Seppo Orsila m. +358 40 830 4671
IR Ulla Haapanen m. +358 40 830 4676
Email: ir@modulight.com

Certified Adviser: Danske Bank A/S, Finland Branch, m. +358 40 414 5358
 
www.modulight.com
Twitter: @modulight

Modulight in brief

Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland. www.modulight.com

Follow Modulight: Twitter | LinkedIn | Facebook | YouTube | Instagram | #killcancer #laserfamily

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Företag
Pressmeddelanden